Affinimark Technologies, a private bioscience company based in New Haven, Connecticut, develops proprietary medical diagnostic products addressing market opportunities and serious unmet medical/surgical needs. Its lead product, CerebrostripTM, is a strip-based diagnostic test, derived from Affinimarkâ€™s own cutting edge research, that will quickly and cost-effectively provide a definitive determination whether a patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. No such product is currently available, resulting in significant risk to the patient and cost to the healthcare system.
Board Members and Advisors (2)Update
300 George Street
New Haven, CT 06511